signatures Archives | Page 182 of 216 | NanoString

Home » signatures » Page 182

March 26, 2019 / Nat Commun.

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Formisano L. et. al.,

March 25, 2019 / Brief Bioinform

Molecular subtyping of cancer: current status and moving toward clinical applications

Zhao L et al.,

March 24, 2019 / bioRxiv

A Transcriptome Fingerprinting Assay for Clinical Immune Monitoring

Altman MC et al.,

March 21, 2019 / Ocul Surf.

Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients

Liang H. et. al.,

March 21, 2019 / Psychopharmacology (Berl)

Microbe and host interaction in gastrointestinal homeostasis

Horne R. et. al.,

March 20, 2019 / Sci Transl Med.

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

Puca L. et. al.,

March 20, 2019 / Cancer Res

Inhibition of miR-328–3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer

Srivastava AK et al.,

March 19, 2019 / Front Immunol.

Adipose Tissue in Persons With HIV Is Enriched for CD4+ T Effector Memory and T Effector Memory RA+ Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance

Wanjalla C.N. et. al.,

March 19, 2019 / Cancer Res

Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer

Kasikara C. et. al.,

March 19, 2019 / Biology (Basel)

Circadian Clocks in Fish—What Have We Learned so far?

Frøland Steindal IA et al.,

March 18, 2019 / Neuro Oncol

Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

Kieran MW et al.,

March 18, 2019 / bioRxiv

Multiplatform Biomarker Identification using a Data-driven Approach Enables Single-sample Classification

Zhang L et al.,

Previous 1 … 180 181 182 183 184 … 216 Next